We have reported that the basal and stimulated cytosolic free calcium concentrations ( ], between cells from hypertensive and normotensive animals reflects the difference in the activated state associated with cell function. Thus, estimation of both basal and agonist-induced [Ca 2+
T
here is considerable evidence of abnormal calcium handling by various tissues and cells isolated from humans and experimental animals with primary hypertension. These results have led to the hypothesis that defective cellular calcium metabolism is a pathogenic factor in the development of hypertension. 1 - 3 Blood cells frequently have been used for the analysis of cellular calcium metabolism because they are readily available and easy to handle. Thus, there have been many reports that basal intracellular free calcium ([Ca 2+ ]|) is increased in lymphocytes 4 - 6 and platelets 5 -7 -11 of patients with essential hypertension and spontaneously hypertensive rats (SHR) in comparison with their respective normotensive controls. However, concern has been raised about using circulating blood cells 12 because of their exposure to the mechanical shear forces in the circulatory system that could alter cellular calcium metabolism or cell function. 13 . 14 17 have yielded variable and controversial results. This descrepancy may be due to methodological problems as we have previously suggested. 7 The present study was undertaken to investigate basal and stimulated [Ca 2+ ]] in blood platelets and thymic lymphocytes isolated from 4-week-old SHR and rats at a time before a significant increase in the young SHR's arterial pressure.
Methods
Male SHR (n = 12) and WKY rats (n=14) were obtained from Charles River Breeding Laboratory, Wilmington, Mass, at 3 weeks of age and maintained on Purina Rodent Chow (5001) and tap water ad libitum in a colony room with fixed light/dark cycles and constant temperature and humidity. At 4 weeks of age, systolic blood pressure was determined by the tail-cuff method and experiments were performed.
Under anesthesia with intraperitoneal ketamine (15 mg/100 g body wt), the thoracic cavity was opened and blood was drained from the inferior vena cava into a syringe containing 3.8% trisodium citrate anticoagulant. Blood from two rats was pooled for each experiment. Platelet isolation and measurement of [Ca 2+ ]j with fura-2 were performed as previously described. 7 After drawing blood, the thymus was carefully removed and rinsed in RPMI-1640 (GIBCO Laboratories, Grand Island, N.Y.). Attached blood vessels and connective tissue were removed. The thymus was minced and the crude suspension was passed through a nylon mesh and layered on a Ficoll-metrizoate suspension with a density of 1087 and centrifuged at 800g for 20 minutes at room temperature. The isolated lymphocytes were washed twice in RPMI-1640 and were incubated with 2 /iM fura-2/acetoxymethylester (Molecular Probes, Eugene, Ore.) at 2xlO 7 cells/ml at 37°C for 30 minutes. The cells were then washed and reincubated at 37°C for 30 minutes in RPMI-1640. The cells were washed twice with media containing (mM) NaCl 145, KC1 5, CaCl 2 1, MgSO 4 1, Na 2 HPO 4 0.5, HEPES 10, and glucose 5 (pH 7.4), and suspended in this solution at 5x10* cells/ml.
Lymphocyte [Ca

2+
]i measurement was performed as in platelets. 7 Briefly, the intact cells were suspended in a quartz cuvette at 37°C and fluorescence was measured with a dual excitation wavelength fluorometer (AR-CM, SPEX Industries Inc., Edison, N.J.) using an emission wavelength of 510 nm and excitation wavelengths of 340 and 380 nm. A correction was applied for extracellular fura-2 leakage using EGTA as described for platelets. 6 Concanavalin A (Sigma Chemical Co., St. Louis, Mo.) was used as a lymphocyte agonist at concentrations of 30 and 100 Mg/ml. All data are presented as mean±SD. Statistical comparisons between the two groups were performed using the Mann-Whitney U test. Similar results were obtained using the unpaired Student's t test. Statistical significance was defined as a value of/?<0.05.
Results
As expected in rats of this age, systolic blood pressure was not different in SHR and WKY rats (95 ±8 versus 92 ±7 mm Hg). Body weight was lower in SHR than WKY rats (58 ±6 versus 70 ±3 g, p=0.0002).
Basal [Ca 2+ ]j in platelets corrected for fura-2 leakage was significantly higher in SHR (63.4±3.9 nM, n=6) than WKY rats (54.8±3.1 nM, n=7,/><0.003) as shown in Figure 1 . Fura-2 leakage was similar in both groups (14.6±2.5% versus 13.4±2.3%). Uncorrected basal platelet [Ca 2+ ]i was also higher in SHR (101.6+8.1 nM) than WKY rats (87.9±5.9 nM, p< 0.005). Peak platelet [Ca 2+ ]j induced by thrombin (0.1 units/ml) was markedly higher in SHR than WKY rats in the presence of extracellular calcium with no overlap between groups (576. ]j response to 0.1 units/ml thrombin measured in a nominally calcium-free media was also higher in SHR than WKY rats (283.1+28.6 versus 250.3 ±12.0 nM, p<0.01). The difference in the thrombin-induced peak of [Ca 2+ ]; in the presence and absence of extracellular calcium was considered to represent thrombin-induced calcium influx across the cell membrane and calcium influx-dependent intracellular calcium release or release of secondary agonists; ], response to the lymphocyte-specific agonist concanavalin A (30 ^g/ml) was higher in SHR than in WKY rats both in calcium-containing (152.4±123 versus 137.9+8.9 nM,p<0.02) and calcium-free media (62.1 ±2.2 versus 57.8±4.4 nM,/?<0.02) (Figure 3 ). The response of [Ca 2+ ]j to 100 jig/ml concanavalin A was also higher in SHR than WKY rats in the presence of extracellular calcium (2073 ±17.5 versus 186.1±17.1 nM, /?<0.02). The difference between concanavalin A (30 /ig/ml)-induced peak [Ca 2+ ]; in the presence and absence of extracellular calcium was also higher in SHR (90.2±12.7 nM) than in WKY rats(80.0±8.6,/?<0.05).
Discussion
We recently reported abnormal calcium handling by fura-2-loaded platelets from 12-14-week-old SHR with overt hypertension compared with agematched normotensive WKY rats using an improved method for measuring [Ca 2+ ]i. 7 However, this result alone does not necessarily indicate that altered cell calcium metabolism plays a primary role in the development of hypertension. For example, shear stresses during cell passage through resistance vessels and capillaries may induce platelet aggregation 13 and changes in cellular calcium metabolism.
14 However, our current results indicate that the processes con- ]j are already modified in blood platelets before the onset of overt hypertension. For platelets, basal and thrombin-stimulated [Ca 2+ ]i, both in the presence and absence of extracellular calcium, were higher in SHR than WKY rats at 4 weeks and 12-14 weeks of age. The level of platelet [Ca 2+ ]j in rats of both strains at 4 weeks of age is quite similar to levels measured in 12-14-week-old rats in our previous report (SHR 61.6±5.6, WKY rats 54.0±3.9 nM). 7 Therefore, neither blood pressure itself nor age determines [Ca 2+ ], in rat platelets. These results argue strongly against the possibility that elevated platelet [Ca \ from SHR results from disturbances induced by high blood pressure.
Previous studies of platelet calcium in prehypertensive SHR have been limited to measurements of basal [Ca 2+ ]j in quin-2-loaded cells. ]j were obscured when no correction for the dye leakage was performed and a relatively small number of samples was examined. The consistency of our results between young and old animals would seem to validate the importance of these factors in the measurement of [Ca 2+ ]i in hematopoietic cells.
The other important finding of this study is that the modification of calcium handling by thymic lymphocytes also exist in 4-week-old SHR. Thymic lymphocytes had lower [Ca 2+ ]j and higher fura-2 leakage than platelets, presumably because of differences in cellular regulating and membrane properties. Although no difference was detected in basal [ 6 have used circulating lymphocytes from SHR, although these studies may be complicated by a heterogeneous T and B cell population and contamination by other blood cells. Our method provides the pure T cell lymphocytes and is also the first report of thymocyte [Ca 2+ ]j from SHR at any age. The finding of altered calcium metabolism in noncirculating T cell lymphocytes from prehypertensive SHR further suggests a primary link between abnormal cell calcium handling and the pathogenesis of hypertension. Furthermore, there have been several reports indicating that T cell lymphocyte function is selectively disturbed in SHR 21 - 22 and that the manipulation of this immune dysfunction has an antihypertensive effect. 23 - 24 Further studies are necessary to investigate the relation between calcium metabolism and cell function in lymphocytes.
In the present study, we found that blood platelets and thymic lymphocytes from SHR share an abnormality in receptor-mediated calcium transients including calcium discharge from intracellular stores. However, alterations in basal [Ca 2+ ] ; appeared only in platelets and not in lymphocytes. Abnormal cell calcium regulation has also been found in vascular muscle cells isolated from neonatal SHR 25 -26 and 4-week-old SHR. 27 Thus, altered cell calcium regulation may exist in a wide variety of tissues and cells of this model of genetic hypertension even in the prehypertensive stage. These findings lend additional credence to the hypothesis that altered cell metabolism is a pathogenetic factor in hypertension. In addition, our findings support the applicability of hematopoietic cells for studies of cellular calcium metabolism in hypertension.
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